← Back to Clinical Trials
Recruiting NCT05942391

NCT05942391 Brief-intensive CBT Versus Once-weekly CBT in Anxiety-related Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05942391
Status Recruiting
Phase
Sponsor Universitair Ziekenhuis Brussel
Condition Anxiety Disorders
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2024-04-26
Primary Completion 2026-03-31

Trial Parameters

Condition Anxiety Disorders
Sponsor Universitair Ziekenhuis Brussel
Study Type INTERVENTIONAL
Phase N/A
Enrollment 120
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-04-26
Completion 2026-03-31
Interventions
Cognitive behavioral therapy (CBT)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to compare brief-intensive cognitive-behaviour therapy (CBT) with regular weekly CBT in people with anxiety-related disorders. The main question to answer is: will brief-intensive CBT improve functioning (work, family, social) more and faster than does regular weekly CBT? Participants will be asked to follow CBT treatment (20 sessions of 45 minutes in both conditions), and participate in 7 measurements with a total duration of 5 hours over 1 year. Researchers will compare: * Brief-intensive CBT: 16 sessions in 2 weeks + 4 follow-up sessions within 3 months * Regular CBT with 20 weekly sessions in 6 months

Eligibility Criteria

Inclusion Criteria: Age 18 years or older; Reaching out for mental health care for one of the following disorders: panic disorder, agoraphobia, generalised anxiety disorder, social anxiety disorder, posttraumatic stress disorder, obsessive-compulsive disorder, health anxiety disorder. Exclusion Criteria: * Is in need of emergency mental health care * Has insufficient language skills in Dutch * Has evident cognitive limitations * Has had changes in the use of medication during the last 3 months.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology